Literature DB >> 24410548

Measuring the mind: assessing cognitive change in clinical drug trials.

John Harrison1, Paul Maruff.   

Abstract

Year:  2008        PMID： 24410548     DOI： 10.1586/17512433.1.4.471

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  8 in total

1.  Safety and efficacy of rivastigmine in adolescents with Down syndrome: long-term follow-up.

Authors:  James H Heller; Gail A Spiridigliozzi; Blythe G Crissman; Jane Anne McKillop; Haru Yamamoto; Priya S Kishnani
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

Review 2.  Assessment of cognition in mild cognitive impairment: a comparative study.

Authors:  Peter J Snyder; Colleen E Jackson; Ronald C Petersen; Ara S Khachaturian; Jeffrey Kaye; Marilyn S Albert; Sandra Weintraub
Journal:  Alzheimers Dement       Date:  2011-05       Impact factor: 21.566

3.  Defining cognitive impairment in people-living-with-HIV: the POPPY study.

Authors:  Davide De Francesco; Jonathan Underwood; Frank A Post; Jaime H Vera; Ian Williams; Marta Boffito; Memory Sachikonye; Jane Anderson; Patrick W G Mallon; Alan Winston; Caroline A Sabin
Journal:  BMC Infect Dis       Date:  2016-10-28       Impact factor: 3.090

4.  The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohort.

Authors:  Roos J Jutten; John E Harrison; A J Brunner; R Vreeswijk; R A J van Deelen; Frank Jan de Jong; Esther M Opmeer; Craig W Ritchie; André Aleman; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (N Y)       Date:  2020-04-17

5.  Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery.

Authors:  Jennifer Rae Myers; Jordan M Glenn; Erica N Madero; John Anderson; Rachel Mak-McCully; Michelle Gray; Joshua L Gills; John E Harrison
Journal:  JMIR Form Res       Date:  2022-02-18

6.  Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men.

Authors:  Jeffrey McDonnell; Lewis Haddow; Marina Daskalopoulou; Fiona Lampe; Andrew Speakman; Richard Gilson; Andrew Phillips; Lorraine Sherr; Sonali Wayal; John Harrison; Andrea Antinori; Paul Maruff; Adrian Schembri; Margaret Johnson; Simon Collins; Alison Rodger
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

7.  Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.

Authors:  Lewis J Haddow; Rosanna Laverick; Marina Daskalopoulou; Jeffrey McDonnell; Fiona C Lampe; Richard Gilson; Andrew Speakman; Andrea Antinori; Pietro Balestra; Tina Bruun; Jan Gerstoft; Lars Nielsen; Anna Vassilenko; Simon Collins; Alison J Rodger
Journal:  AIDS Behav       Date:  2018-05

8.  Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.

Authors:  John E Harrison; Harry Barry; Bernhard T Baune; Michael W Best; Christopher R Bowie; Danielle S Cha; Larry Culpepper; Philippe Fossati; Tracy L Greer; Catherine Harmer; Esther Klag; Raymond W Lam; Yena Lee; Rodrigo B Mansur; Hans-Ulrich Wittchen; Roger S McIntyre
Journal:  Int J Methods Psychiatr Res       Date:  2018-08-07       Impact factor: 4.035
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.